Skip to main content
TipRanks
Go Ultimate75% OFF

Fuji Pharma Co., Ltd. (4554) Income Statement

0 Followers

Fuji Pharma Co., Ltd. Income Statement

Last quarter (Q4 2026), Fuji Pharma Co., Ltd.'s total revenue was ¥17.00B, an increase of 15.49% from the same quarter last year. In Q4, Fuji Pharma Co., Ltd.'s net income was ¥1.01B. See Fuji Pharma Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementSep 26Sep 25Sep 24Sep 23Sep 22
¥ 62.39B¥ 51.68B¥ 46.14B¥ 40.89B¥ 35.43B
¥ 22.77B¥ 19.29B¥ 16.51B¥ 15.37B¥ 13.62B
¥ 16.42B¥ 14.30B¥ 12.63B¥ 11.52B¥ 9.84B
Depreciation and Amortization¥ 0.00¥ 3.96B¥ 3.68B¥ 3.02B¥ 2.75B
¥ 6.36B¥ 8.96B¥ 7.56B¥ 6.88B¥ 6.52B
¥ 6.36B¥ 4.99B¥ 3.88B¥ 3.86B¥ 3.78B
¥ -3.20B¥ -990.00M¥ 4.39B¥ 540.00M¥ -55.00M
¥ 3.15B¥ 4.00B¥ 8.28B¥ 4.40B¥ 3.72B
¥ 2.83B¥ 3.00B¥ 6.15B¥ 3.44B¥ 2.70B
Per Share Metrics
Basic EPS¥ 111.18¥ 122.93¥ 252.81¥ 141.35¥ 110.98
Diluted EPS¥ 111.18¥ 122.93¥ 252.81¥ 141.35¥ 110.98
Weighted Average Shares Outstanding25.46M24.40M24.31M24.30M24.29M
Weighted Average Shares Outstanding (Diluted)25.46M24.40M24.31M24.30M24.29M

Currency in JPY

Fuji Pharma Co., Ltd. Earnings and Revenue History

025B50B75B4 %8 %12 %16 %EarningsProfit Margin2017201820192020202120222023202420252026RevenueEarningsProfit Margin